RecruitingNot ApplicableNCT07035431

Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area

A Prospective Multicenter Trial Evaluating the Safety and Effectiveness of Endo-SPONGE for the Treatment of Anastomotic or Hartmann's Stump Leakages in the Lower Pelvic Area


Sponsor

Boston Scientific Corporation

Enrollment

66 participants

Start Date

Mar 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study is intended to evaluate the safety and effectiveness of Sponge-based Endoscopic Vacuum Therapy (EVT) using Endo-SPONGE for the treatment of Anastomotic Leaks (AL) or Hartmann's stump leakages following colorectal surgery in a prospective multi-center study.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Confirmed grade B anastomotic leak as per the ISGRC (International Study Group of Rectal Cancer) grading system after colorectal surgery.
  • Subject is eligible for endoscopic intervention.
  • Subject has a transmural defect of at least 2 cm in diameter following colorectal surgery in the lower pelvic area.
  • Subject has an anastomotic or Hartmann's stump leak located within an extraperitoneal cavity.
  • Subject has pre-existing diverting ostomy or an ostomy created prior to the first Endo-SPONGE placement.
  • Subject understands the trial requirements and is willing and able to comply with the study procedures, all protocol-required follow up evaluations and provide written informed consent to participate in the study.
  • Investigator decision that EVT is the most suitable treatment of the available treatment options.

Exclusion Criteria7

  • Subject is under 18 years of age.
  • Potentially vulnerable subject, including, but not limited to pregnant women.
  • Subject has undergone EVT or other similar interventions for the current colorectal indication.
  • Subject had colorectal surgery more than 60 days prior to the planned study procedure.
  • Subject has any necrotic tissue that would require endoscopic debridement prior to Endo-SPONGE placement.
  • Subject has known contraindication for EVT as per the IB.
  • Subject is currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEndo-SPONGE

The intervention involves the placement of an Endo-SPONGE in the leakage cavity, and applying suction to facilitate drainage.


Locations(6)

Mount Sinai

New York, New York, United States

Ohio State University Medical Center

Columbus, Ohio, United States

Penn State Health

Hershey, Pennsylvania, United States

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States

University of Washington Medical Center

Seattle, Washington, United States

Marshall University Medical Center

Huntington, West Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07035431


Related Trials